The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond

Frontiers in Neurology
Nayana GaurJulian Grosskreutz

Abstract

Amyotrophic lateral sclerosis (ALS) is a late-onset neurodegenerative condition, most widely characterized by the selective vulnerability of motor neurons and the poor life expectancy of afflicted patients. Limited disease-modifying therapies currently exist, which only further attests to the substantial heterogeneity associated with this disease. In addition to established prognostic factors like genetic background, site of onset, and age at onset, wide consensus on the role of neuroinflammation as a disease exacerbator and driver has been established. In lieu of this, the emerging literature on chitinases in ALS is particularly intriguing. Individual groups have reported substantially elevated chitotriosidase (CHIT1), chitinase-3-like-1 (CHI3L1), and chitinase-3-like-2 (CHI3L2) levels in the cerebrospinal, motor cortex, and spinal cord of ALS patients with multiple-and often conflicting-lines of evidence hinting at possible links to disease severity and progression. This mini-review, while not exhaustive, will aim to discuss current evidence on the involvement of key chitinases in ALS within the wider framework of other neurodegenerative conditions. Implications for understanding disease etiology, developing immunomodulatory ...Continue Reading

References

Sep 15, 2005·The Journal of Allergy and Clinical Immunology·Jack A EliasChun Geun Lee
Jul 5, 2006·The European Journal of Neuroscience·Michelino Di RosaLucia Malaguarnera
Jun 15, 2010·Journal of Neuroinflammation·Dafna Bonneh-BarkayClayton A Wiley
Dec 17, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Jorge Correale, Marcela Fiol
Dec 24, 2010·Brain, Behavior, and Immunity·David R BeersJenny S Henkel
Nov 7, 2012·Molecular and Cellular Biochemistry·Michelino Di RosaLucia Malaguarnera
Nov 15, 2012·Inflammation·Michelino Di RosaLucia Malaguarnera
Nov 16, 2012·Cell Biochemistry and Biophysics·Michelino Di RosaLucia Malaguarnera
Jan 10, 2013·PloS One·Philippe CorciaMaria-Joao Ribeiro
Dec 4, 2013·Clinical Proteomics·Anu Mary VargheseTrichur R Raju
Jan 3, 2014·Annals of Neurology·Elisabetta PupilloUNKNOWN SLALOM Group
Jan 23, 2014·Journal of Neurochemistry·Cao HuangHongxia Zhou
Jan 15, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Seward B Rutkove
Jul 2, 2015·Journal of Neuroinflammation·Jared EhrhartSvitlana Garbuzova-Davis
Feb 13, 2016·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M MøllgaardS Modvig
Feb 26, 2016·Acta Neuropathologica·Lisa ZondlerJochen H Weishaupt
Sep 23, 2016·PloS One·Filipe Brogueira RodriguesEdward J Wild
Jun 11, 2017·Journal of Neuroinflammation·Marta Querol-VilasecaAlberto Lleó
Oct 11, 2017·Molecular and Cellular Neurosciences·C SanfilippoM Di Rosa
Jan 14, 2018·Annals of Neurology·Alexander G ThompsonMartin R Turner
Mar 30, 2018·Journal of Neuroinflammation·Caroline PernerJulian Grosskreutz
May 8, 2018·Cancer Chemotherapy and Pharmacology·Nikolai LitviakovJulia Kzhyshkowska
Jul 29, 2018·Journal of Neurology·Kevin TalbotMartin R Turner
Sep 19, 2018·Journal of Neurology, Neurosurgery, and Psychiatry·Patrick OecklMarkus Otto
Oct 7, 2018·Neurology·Ignacio Illán-GalaAlberto Lleó
Oct 24, 2018·Annals of Clinical and Translational Neurology·Marta Del CampoCharlotte E Teunissen
Jan 16, 2019·Nature Communications·Sarah C StarossomSamia J Khoury
Jan 25, 2019·Proceedings of the National Academy of Sciences of the United States of America·Emmanuelle CoqueCédric Raoul
Feb 23, 2019·Journal of Neuroinflammation·Kaja NordengenTormod Fladby
May 28, 2019·Journal of Neurology, Neurosurgery, and Psychiatry·Alexander G ThompsonMartin R Turner
Jun 9, 2019·Journal of Neurology, Neurosurgery, and Psychiatry·Benjamin GilleKoen Poesen

❮ Previous
Next ❯

Citations

May 1, 2021·Nature Reviews. Neurology·Björn F VahsenMartin R Turner
Aug 7, 2021·Biochimica Et Biophysica Acta. Proteins and Proteomics·Zhengqiang JiangShaoqing Yang
Aug 1, 2021·Molecular Diagnosis & Therapy·Jesús García-FoncillasMaría Vanessa Pérez Gómez
Sep 13, 2021·Clinical and Experimental Immunology·Sandra AmorFabiola Puentes
Nov 12, 2021·Expert Review of Proteomics·Alexander G ThompsonMartin R Turner
Dec 17, 2021·Journal of Neurology, Neurosurgery, and Psychiatry·Pegah MasroriPhilip Van Damme

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging
transgenic
ELISA
Enzyme-linked Immunosorbent

Related Concepts

Related Feeds

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
Michael Swash
Surgical Neurology International
Sara ZareiAngel Chinea
CNS & Neurological Disorders Drug Targets
Vineeta B Tripathi, Ammar Al-Chalabi
Neural Regeneration Research
Stéphane MathisGwendal Le Masson
© 2022 Meta ULC. All rights reserved